| Name | Walgreens #10430 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 103 W Central Ave, Petal, Mississippi 39465 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (601) 554-3236 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of the RADAR Phase 2b clinical trial for the Company's lead product, the REG1 anticoagulation system, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo.
Bristol-Myers Squibb announced today that BARACLUDE(R) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B in adult patients with evidence of decompensated liver disease.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
Queensland scientists have discovered a drug to cure cancer that has effectively worked in animals and is to be tried on humans in the next phase of trials. This drug is plant-derived and is called EBC-46 for trial purposes. The plant from which it is obtained is found in the Australian tropical rainforest. The drug has shown to reduce inoperable tumors in 150 dogs, cats and horses and a ferret to a significant extent. The drug was developed over the past six years from the seed of a rainforest plant found in the Atherton Tablelands. Scientists had cultivated their own plantation of the plant since forming the company QBiotics Limited in 2004.
› Verified 8 days ago
| NPI Number | 1568562346 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #10430 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 103 W Central Ave, Petal, MS 39465 |
| Phone Number | 601-554-3236 |
News Archive
Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of the RADAR Phase 2b clinical trial for the Company's lead product, the REG1 anticoagulation system, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo.
Bristol-Myers Squibb announced today that BARACLUDE(R) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B in adult patients with evidence of decompensated liver disease.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
Queensland scientists have discovered a drug to cure cancer that has effectively worked in animals and is to be tried on humans in the next phase of trials. This drug is plant-derived and is called EBC-46 for trial purposes. The plant from which it is obtained is found in the Australian tropical rainforest. The drug has shown to reduce inoperable tumors in 150 dogs, cats and horses and a ferret to a significant extent. The drug was developed over the past six years from the seed of a rainforest plant found in the Atherton Tablelands. Scientists had cultivated their own plantation of the plant since forming the company QBiotics Limited in 2004.
› Verified 8 days ago
News Archive
Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of the RADAR Phase 2b clinical trial for the Company's lead product, the REG1 anticoagulation system, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo.
Bristol-Myers Squibb announced today that BARACLUDE(R) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B in adult patients with evidence of decompensated liver disease.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
Queensland scientists have discovered a drug to cure cancer that has effectively worked in animals and is to be tried on humans in the next phase of trials. This drug is plant-derived and is called EBC-46 for trial purposes. The plant from which it is obtained is found in the Australian tropical rainforest. The drug has shown to reduce inoperable tumors in 150 dogs, cats and horses and a ferret to a significant extent. The drug was developed over the past six years from the seed of a rainforest plant found in the Atherton Tablelands. Scientists had cultivated their own plantation of the plant since forming the company QBiotics Limited in 2004.
› Verified 8 days ago
Wal-mart Pharmacy 10-0887 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 36 Byrd Blvd, Petal, Mississippi 39465 Phone: (601) 584-7525 | |
Walgreens #10430 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 103 W Central Ave, Petal, Mississippi 39465 Phone: (601) 554-3236 | |
Moreno Eye Care Type: Medicare Supplier Location: 598 E Central Ave, Petal, Mississippi 39465 Phone: (601) 450-3937 |